Indian Company Master Data Made Simple
Indoco Remedies Limited
Indoco Remedies Limited has been active since 1947, providing more than 79 years of industry experience. Its CIN is L85190MH1947PLC005913, with registration number 5913. Indoco Remedies Limited is registered as company limited by shares. Its authorized capital has been set at ₹25.00 crore. The paid-up share capital amounts to ₹18.44 crore.
Indoco Remedies Limited primarily operates in health and social work. The company has been registered in the city of Mumbai. The firm’s incorporation address reads Indoco House 166 Cst Roadvidyanagari Marg Kalina Santacruz East, Mumbai, Maharashtra, India, 400098. It is officially listed as an active business entity. Its registered PAN is AAACI0380C as per government records. The entity’s LEI (Legal Entity Identifier) number is 3358007XE9RRPHJA6U47. The firm’s registered email for correspondence is ramanathan.hariharan@indoco.com. Indoco Remedies Limited’s leading executives are Pramod Ramchandra Ghorpade (CFO).
Company Overview
- CIN
- Date of Incorporation
- 22/08/1947
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹25,00,00,000.00
- Paid up Capital
- ₹18,43,64,410.00
- Activity
- Health And Social Work
- ramanathan.hariharan@indoco.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Andhra Pradesh | 37AAACI0380C1Z2 | Inactive |
| Assam | 18AAACI0380C2Z1 | Inactive |
| 18AAACI0380C1Z2 | Active | |
| Bihar | 10AAACI0380C1ZI | Active |
| Chhattisgarh | 22AAACI0380C1ZD | Active |
| Chandigarh | 04AAACI0380C1ZB | Inactive |
| Delhi | 07AAACI0380C1Z5 | Active |
| Gujarat | 24AAACI0380C1Z9 | Active |
| Goa | 30AAACI0380C1ZG | Active |
| Haryana | 06AAACI0380C1Z7 | Inactive |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE873D01024 | INDOCO REMEDIES LIMITED EQ NEW FV RS.2/- | - | 12/10/2026 | INDOCO REMEDIES/SH VTG | ESVUFN |
| IN8873D01015 | INDOCO REMEDIES LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | INDOCO REMEDIES/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹1,08,219.00L | ₹1,21,307.23L | ₹97,928.10L | ₹70,630.11L | ₹0.00L |
| Net Debt | ₹1,00,992.00L | ₹96,593.30L | ₹64,029.28L | ₹30,357.98L | ₹0.00L |
| Goodwill | ₹2,152.00L | ₹2,152.00L | ₹2,152.11L | ₹9.00L | ₹0.00L |
| Gross PPE | ₹1,08,219.00L | ₹1,83,174.91L | ₹1,53,259.13L | ₹1,20,730.86L | ₹0.00L |
| Inventory | ₹40,521.00L | ₹41,935.43L | ₹35,306.35L | ₹32,598.55L | ₹0.00L |
| Total Debt | ₹1,08,975.00L | ₹99,356.68L | ₹67,195.33L | ₹33,285.07L | ₹0.00L |
| Common Stock | ₹1,846.00L | ₹1,844.96L | ₹1,843.65L | ₹1,843.01L | ₹0.00L |
| Current Debt | ₹51,983.00L | ₹44,483.00L | ₹30,342.18L | ₹17,100.45L | ₹0.00L |
| Share Issued | ₹923.04L | ₹922.48L | ₹921.82L | ₹921.50L | ₹0.00L |
| Total Assets | ₹2,59,327.00L | ₹2,42,991.36L | ₹2,14,472.85L | ₹1,65,819.84L | ₹0.00L |
| Capital Stock | ₹1,846.00L | ₹1,844.96L | ₹1,843.65L | ₹1,843.01L | ₹0.00L |
| Long Term Debt | ₹51,602.00L | ₹53,319.66L | ₹35,172.67L | ₹14,350.00L | ₹0.00L |
| Current Assets | ₹1,19,335.00L | ₹1,00,133.82L | ₹95,466.83L | ₹81,356.80L | ₹0.00L |
| Working Capital | ₹14,081.00L | ₹19,334.42L | ₹34,233.97L | ₹38,906.10L | ₹0.00L |
| Invested Capital | ₹1,97,513.00L | ₹2,00,002.58L | ₹1,76,504.86L | ₹1,34,275.61L | ₹0.00L |
| Other Properties | ₹1,05,390.00L | ₹35,374.48L | ₹32,208.25L | ₹28,697.33L | ₹0.00L |
| Common Stock Equity | ₹93,928.00L | ₹1,02,199.64L | ₹1,10,990.01L | ₹1,02,825.16L | ₹0.00L |
| Net Tangible Assets | ₹73,835.00L | ₹82,975.68L | ₹92,188.45L | ₹90,398.29L | ₹0.00L |
| Tangible Book Value | ₹73,835.00L | ₹82,975.68L | ₹92,188.45L | ₹90,398.29L | ₹0.00L |
| Current Liabilities | ₹1,05,254.00L | ₹80,799.40L | ₹61,232.86L | ₹42,450.70L | ₹0.00L |
| Stockholders Equity | ₹93,928.00L | ₹1,02,199.64L | ₹1,10,990.01L | ₹1,02,825.16L | ₹0.00L |
| Other Equity Interest | ₹92,082.00L | ₹573.79L | ₹353.72L | ₹65.75L | ₹0.00L |
| Total Capitalization | ₹1,45,530.00L | ₹1,55,519.30L | ₹1,46,162.68L | ₹1,17,175.16L | ₹0.00L |
| Ordinary Shares Number | ₹921.74L | ₹921.61L | ₹921.50L | ₹921.50L | ₹0.00L |
| Other Intangible Assets | ₹17,941.00L | ₹17,071.85L | ₹16,649.45L | ₹12,417.87L | ₹0.00L |
| Other Non Current Assets | ₹9,896.00L | ₹0.06L | ₹9,966.00L | ₹4,650.00L | ₹0.00L |
| Total Non Current Assets | ₹1,39,991.00L | ₹1,42,857.54L | ₹1,19,006.02L | ₹84,463.04L | ₹0.00L |
| Cash And Cash Equivalents | ₹2,593.00L | ₹1,209.64L | ₹1,485.57L | ₹1,092.47L | ₹0.00L |
| Construction In Progress | ₹2,829.00L | ₹36,401.16L | ₹19,106.65L | ₹9,411.05L | ₹0.00L |
| Other Short Term Investments | ₹1,991.00L | ₹322.02L | ₹1,073.69L | ₹399.49L | ₹0.00L |
| Other Non Current Liabilities | ₹750.00L | ₹740.92L | ₹736.38L | ₹736.38L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹20,093.00L | ₹19,223.96L | ₹18,801.56L | ₹12,426.87L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹93,211.00L | ₹1,01,837.85L | ₹1,11,049.66L | ₹1,02,825.16L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹1,66,116.00L | ₹1,41,153.51L | ₹1,03,423.19L | ₹62,994.68L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹53,139.00L | ₹45,100.77L | ₹30,782.11L | ₹17,431.39L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹55,836.00L | ₹54,255.91L | ₹36,413.22L | ₹15,853.68L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹4,584.00L | ₹1,531.66L | ₹2,559.26L | ₹1,491.96L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹60,862.00L | ₹60,354.11L | ₹42,190.33L | ₹20,543.98L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | ₹10,100.00L | -₹16,767.00L | -₹27,060.49L | -₹2,842.27L | ₹0.00L |
| Changes In Cash | ₹588.00L | -₹41.00L | ₹330.64L | -₹654.05L | ₹0.00L |
| End Cash Position | ₹1,294.00L | ₹706.00L | ₹1,485.57L | ₹1,092.47L | ₹0.00L |
| Financing Cash Flow | -₹13,309.00L | ₹16,862.00L | ₹12,239.00L | ₹2,280.40L | ₹0.00L |
| Investing Cash Flow | -₹8,738.00L | -₹25,979.00L | -₹43,251.53L | -₹20,817.24L | ₹0.00L |
| Operating Cash Flow | ₹22,635.00L | ₹9,076.00L | ₹15,538.71L | ₹17,882.79L | ₹0.00L |
| Capital Expenditure | -₹12,535.00L | -₹25,843.00L | -₹42,599.20L | -₹20,725.06L | ₹0.00L |
| Beginning Cash Position | ₹706.00L | ₹747.00L | ₹1,092.47L | ₹1,746.52L | ₹0.00L |
| Issuance Of Capital Stock | ₹130.00L | ₹159.00L | ₹77.34L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹1,574.00L | -₹814.00L | ₹17,072.82L | ₹21,654.24L | ₹0.00L |
| EBITDA | ₹14,219.00L | ₹10,570.00L | ₹26,259.35L | ₹28,714.86L | ₹0.00L |
| Net Income | -₹9,515.00L | -₹7,374.00L | ₹9,846.01L | ₹14,225.15L | ₹15,480.00L |
| Gross Profit | ₹1,25,120.00L | ₹1,14,311.00L | ₹1,20,612.05L | ₹1,10,073.44L | ₹0.00L |
| Pretax Income | -₹10,651.00L | -₹7,437.00L | ₹13,579.85L | ₹19,279.21L | ₹0.00L |
| Tax Provision | -₹781.00L | ₹358.00L | ₹3,879.47L | ₹5,054.06L | ₹0.00L |
| Total Revenue | ₹1,79,294.00L | ₹1,64,129.00L | ₹1,78,821.55L | ₹1,64,004.80L | ₹1,54,204.00L |
| Cost Of Revenue | ₹54,174.00L | ₹49,818.00L | ₹58,209.50L | ₹53,931.36L | ₹0.00L |
| Total Expenses | ₹1,77,759.00L | ₹1,65,587.00L | ₹1,64,535.46L | ₹1,44,240.91L | ₹0.00L |
| Interest Expense | ₹12,225.00L | ₹6,623.00L | ₹3,492.97L | ₹2,375.03L | ₹0.00L |
| Operating Income | ₹1,535.00L | -₹1,458.00L | ₹14,286.09L | ₹19,763.89L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹14,513.00L | ₹10,471.00L | ₹25,930.71L | ₹28,845.89L | ₹0.00L |
| Normalized Income | -₹9,242.56L | -₹7,443.30L | ₹9,611.26L | ₹14,321.83L | ₹0.00L |
| Operating Expense | ₹1,23,585.00L | ₹1,15,769.00L | ₹1,06,325.96L | ₹90,309.55L | ₹0.00L |
| Operating Revenue | ₹1,79,294.00L | ₹1,64,129.00L | ₹1,78,821.55L | ₹1,64,004.80L | ₹0.00L |
| Net Interest Income | -₹12,225.00L | -₹6,623.00L | -₹3,505.05L | -₹2,469.18L | ₹0.00L |
| Total Unusual Items | -₹294.00L | ₹99.00L | ₹328.64L | -₹131.03L | ₹0.00L |
| Other Operating Expenses | ₹65,655.00L | ₹59,746.00L | ₹30,237.75L | ₹26,240.00L | ₹0.00L |
| Reconciled Depreciation | ₹10,690.00L | ₹9,825.00L | ₹9,186.53L | ₹7,060.62L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹54,174.00L | ₹49,818.00L | ₹58,209.50L | ₹53,931.36L | ₹0.00L |
| Tax Effect Of Unusual Items | -₹21.56L | ₹29.70L | ₹93.89L | -₹34.35L | ₹0.00L |
| Interest Expense Non Operating | ₹12,225.00L | ₹6,623.00L | ₹3,492.97L | ₹2,375.03L | ₹0.00L |
| Net Income Common Stockholders | -₹9,515.00L | -₹7,374.00L | ₹9,846.01L | ₹14,225.15L | ₹0.00L |
| Net Income Continuous Operations | -₹9,870.00L | -₹7,795.00L | ₹9,700.38L | ₹14,225.15L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | -₹9,515.00L | -₹7,374.00L | ₹9,846.01L | ₹14,225.15L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹294.00L | ₹99.00L | ₹328.64L | -₹131.03L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹12,225.00L | -₹6,623.00L | -₹3,505.05L | -₹2,469.18L | ₹0.00L |
| Net Income Including Noncontrolling Interests | -₹9,870.00L | -₹7,795.00L | ₹9,700.38L | ₹14,225.15L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | -₹9,515.00L | -₹7,374.00L | ₹9,846.01L | ₹14,225.15L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | -₹9,515.00L | -₹7,374.00L | ₹9,846.01L | ₹14,225.15L | ₹0.00L |
Company Performance (FY22–FY26)
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 02/07/1963 | Suresh Govind Kare | 00179220 | Director | View other directorships |
| 27/03/2004 | Aditi Milind Panandikar | 00179113 | Managing Director | View other directorships |
| 27/03/2004 | Sundeep Vasant Bambolkar | 00176613 | Managing Director | View other directorships |
| 28/05/2014 | Anand Madhusudan Nadkarni | 06881461 | Director | View other directorships |
| 27/03/2020 | Vasudha Vasant Kamat | 07500096 | Director | View other directorships |
| 03/10/2020 | Abhijit Yashawant Gore | 00301688 | Director | View other directorships |
| 02/11/2021 | Pramod Ramchandra Ghorpade | *****4793M | CFO | |
| 01/12/2022 | Ramanathan Hariharan | *****1671C | Company Secretary | |
| 01/04/2024 | Satish Madhav Shenoy | 00230711 | Director | View other directorships |
| 01/04/2024 | Ajay Prasan Mulgaokar | 10457626 | Director | View other directorships |
Business Network
Directors 10
- Aditi Milind PanandikarManaging Director
- Sundeep Vasant BambolkarManaging Director
- Ajay Prasan MulgaokarDirector
- Satish Madhav ShenoyDirector
- Abhijit Yashawant GoreDirector
- Vasudha Vasant KamatDirector
- Anand Madhusudan NadkarniDirector
- Suresh Govind KareDirector
- Ramanathan HariharanCompany Secretary
- Pramod Ramchandra GhorpadeCFO
Latest Documents
| Date | Title | Size |
|---|---|---|
| 14/11/2024 | Form MGT-7-14112024 | - |
| 07/11/2024 | Form AOC-4(XBRL)-24102024 | - |
| 28/03/2024 | Form Addendum to AOC-4 CSR-28032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Ajooni Biotech Limited | L85190PB2010PLC040162 | D-118, Industrial Area Phase-7, Mohali, Mohali, Punjab, India, 160059 |
| Hanman Fit Limited | L85190MH2013PLC240311 | 702 Concord Chs Ltd.,jvpd Scheme Plot No.1 Near Shiv Sagar Hotel,n.s.road Vile Parl, E [w], Mumbai City, Mumbai, Maharashtra, India, 400056 |
| Kashipur Sugar Mills Limited | L85191UP1972PLC003545 | 13civil Lines Bareilly Utter Pradesh Up 243005 In |
| Kaya Limited | L85190MH2003PLC139763 | 23/c, Mahal Industrial Estate, Mahakali Caves Road Near Paperbox Lane,andheri (east), Mumbai City, Mumbai, Maharashtra, India, 400093 |
| Wyeth Limited | L85190MH1947PLC005963 | Level 6; Platina; Plot No. C-59; G Block; Bandra - Kurla Complex; Bandra (e); Mumbai; Maharashtra; 400098; India |
Address
Frequently Asked Questions
The current board member of Indoco Remedies Limited are:
- Aditi Milind Panandikar
- Abhijit Yashawant Gore
- Sundeep Vasant Bambolkar
- Anand Madhusudan Nadkarni
- Suresh Govind Kare
- Vasudha Vasant Kamat
- Satish Madhav Shenoy
- Ajay Prasan Mulgaokar